Cinética y capacidad neutralizante de los anticuerpos homólogos y ...

Referencias Bibliográficas
125. Young PR, Hilditch PA, Bletchly C, Halloran W. An antigen capture enzyme-linked
immunosorbent assay reveals high levels of the dengue virus protein NS1 in the sera of
infected patients. J Clin Microbiol 2000;38(3):1053-7.
126. Kurane I, Brinton MA, Samson AL, Ennis FA. Dengue virus-specific, human CD4+
CD8- cytotoxic T-cell clones: multiple patterns of virus cross-reactivity recognized by
NS3-specific T-cell clones. J Virol 1991;65(4):1823-8.
127. Kurane I, Zeng L, Brinton MA, Ennis FA. Definition of an epitope on NS3
recognized by human CD4+ cytotoxic T lymphocyte clones cross-reactive for dengue virus
types 2, 3, and 4. Virology 1998;240(2):169-74.
128. Zivny J, Kurane I, Leporati AM, Ibe M, Takiguchi M, Zeng LL, et al. A single nineamino
acid peptide induces virus-specific, CD8+ human cytotoxic T lymphocyte clones of
heterogeneous serotype specificities. J Exp Med 1995;182(3):853-63.
129. Gubler D. Dengue and dengue hemorrhagic fever: its history and resurgence as a
global public health problem. In: Gubler D, Kuno G, editors. Dengue and Dengue
Hemorrhagic Fever: CAB International; 1997. p. 1-22.
130. Chaturvedi UC, Elbishbishi EA, Agarwal R, Raghupathy R, Nagar R, Tandon R, et
al. Sequential production of cytokines by dengue virus-infected human peripheral blood
leukocyte cultures. J Med Virol 1999;59(3):335-40.
131. Halstead SB, O'Rourke EJ. Dengue viruses and mononuclear phagocytes. I.
Infection enhancement by non-neutralizing antibody. J Exp Med 1977;146(1):201-17.
132. Hall WC, Crowell TP, Watts DM, Barros VL, Kruger H, Pinheiro F, et al.
Demonstration of yellow fever and dengue antigens in formalin-fixed paraffin-embedded
human liver by immunohistochemical analysis. Am J Trop Med Hyg 1991;45(4):408-17.
133. Boonpucknavig S, Vuttiviroj O, Bunnag C, Bhamarapravati N, Nimmanitya S.
Demonstration of dengue antibody complexes on the surface of platelets from patients with
dengue hemorrhagic fever. Am J Trop Med Hyg 1979;28(5):881-4.
134. Killen H, O'Sullivan MA. Detection of dengue virus by in situ hybridization. J Virol
Methods 1993;41(2):135-46.
135. King CA, Marshall JS, Alshurafa H, Anderson R. Release of vasoactive cytokines
by antibody-enhanced dengue virus infection of a human mast cell/basophil line. J Virol
2000;74(15):7146-50.
136. Kurane I, Ennis FA. Cytotoxic T lymphocytes in dengue virus infection. Curr Top
Microbiol Immunol 1994;189:93-108.
137. Kurane I, Innis BL, Hoke CH, Jr., Eckels KH, Meager A, Janus J, et al. T cell
activation in vivo by dengue virus infection. J Clin Lab Immunol 1995;46(1):35-40.
138. Kurane I, Takasaki T. Dengue fever and dengue haemorrhagic fever: challenges of
controlling an enemy still at large. Rev Med Virol 2001;11(5):301-11.
139. Boonpucknavig S, Bhamarapravati N, Nimmannitya S, Phalavadhtana A, Siripont J.
Immunofluorescent staining of the surfaces of lymphocytes in suspension from patients
with dengue hemorrhagic fever. Am J Pathol 1976;85(1):37-48.
140. Malasit P. Complement and dengue haemorrhagic fever/shock syndrome. Southeast
Asian J Trop Med Public Health 1987;18(3):316-20.
141. Hober D, Poli L, Roblin B, Gestas P, Chungue E, Granic G, et al. Serum levels of
tumor necrosis factor-alpha (TNF-alpha), interleukin-6 (IL-6), and interleukin-1 beta (IL-1
beta) in dengue-infected patients. Am J Trop Med Hyg 1993;48(3):324-31.
128